Cytogenomics plays an essential role in the detection and characterisation of chromosomal abnormalities.
Thanks to molecular technologies, we are now able to provide increasingly precise definitions of these alterations.
Our teams, trained in both molecular biology and conventional karyotyping, are regularly called upon for quality control tests related to cell therapy.